Andrew Hore – Quoted Micro 31 May 2021
AQUIS STOCK EXCHANGE Pharma C Investments (PCIL) is a shell seeking to invest in medicinal cannabis sector-focused companies, particularly those that provide ancillary products and services to the sector, and it joined the Access segment on 26 May. The indication is that plant genetics, product testing, marketing, procurement services and cannabis consumption devices are areas […]
Andrew Hore – Quoted Micro 12 April 2021
AQUIS STOCK EXCHANGE Virgata Services is making a 50p a share cash offer for Walls & Futures REIT (WAFR) and that is a 52% discount to net assets at the end of September 2020. It is a premium to the market price prior to the announcement, but management recommends shareholders take no action. The bid […]
Andrew Hore – Quoted Micro 6 April 2021
AQUIS STOCK EXCHANGE Good Energy (GOOD) says that customer numbers have remained stable since September. The 2020 figures will be published on 13 April. There was £18.1m in the bank at the end of 2020. Good has restructured its two renewable generation debts into one debt facility of £39.8m. Arbuthnot Banking Group (ARBB) has completed […]
Andrew Hore – Quoted Micro 11 January 2021
AQUIS STOCK EXCHANGE Standard list shell Baskerville Capital (BASK) plans to switch its quotation to the Access segment of the Aquis Stock Exchange. This move will happen at the time of the reverse takeover of Oberon Investments, the owner of fund manager MD Barnard. The transfer to the Access segment is expected to happen on […]
Andrew Hore – Quoted Micro 4 January 2021
AQUIS STOCK EXCHANGE BWA (BWAP) has been unable to sell Kings of The North Corp (KOTN) back to St Georges Eco-Mining and there are problems with the title to claims held by KOTN. It appears that two licences had not been renewed by St Georges. Three more licence areas are being reviewed. St Georges has […]
Andrew Hore – Quoted Micro 28 December 2020
AQUIS STOCK EXCHANGE TruSpine Technologies (TSP) has delayed the application for FDA approval of its Cervi-LOK spinal device for up to three months. This is due to a lack of testing time because of Covid-19. Computer modelling has enabled the company to make minor modifications, which widens the market for the device. A £250,000 cash […]
Andrew Hore – Quoted Micro 26 October 2020
AQUIS STOCK EXCHANGE Truspine Technologies (TSP) says that the latest tests of Cervi-Lok, which is a spinal stabilisation device, have been positive. The tests used a computer-generated model and it showed that Cervi-Lok had a reduction in range of motion that was better than existing screw-based fixation systems. FDA clearance is expected early next year. […]
Andrew Hore – Quoted Micro 21 September 2020
AQUIS STOCK EXCHANGE Renewable energy supplier Good Energy (GOOD) improved interim revenues by 6% to £67.5m. Gross margins declined as Good Energy focused on business customers. There was a slump from profit to loss, partly down to expected credit losses. There is no interim dividend, but payments should resume next year. Newbury Racecourse (NYR) reported […]
Andrew Hore – Quoted Micro 24 August 2020
AQUIS STOCK EXCHANGE Medical device developer TruSpine Technologies (TSP) ended the week at 34.5p (32p/37p). TruSpine has raised £1.4m at 36p a share with a commitment for a further £250,000. This should provide enough cash until Cervi-Lok, which is one of the three spinal stabilisation devices being developed, starts to generate sales. Coinsilium Group Ltd […]
Andrew Hore – Quoted Micro 17 August 2020
AQUIS STOCK EXCHANGE Brewer Adnams (ADB) reported a slump in revenues from £34.7m to £21m in the six months to June 2020 and there was a loss. That is no surprise given the problems of the hospitality sector. Online sales grew but could not offset the loss of on-trade sales. Net debt was £14m at […]